New patient preference survey confirms that patients value clear skin the most, but expect ...
FREMONT, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), an emerging ...
-- New drug applications for omadacycline accepted for priority review by FDA; PDUFA action ...
